Patient Engagement for Medicines Development in a nutshell

Subscribe to our newsletter


About this program

Patient Focused Medicines Development (PFMD) aims to transform the way in which we understand, engage, and partner with patients globally in the design and development of research and medicines by focusing on unmet patient needs. We are bringing together and synergizing disparate but complementary efforts that integrate the voice of the PATIENT across the lifecycle of medicine. PFMD was established in October 2015 as an open, independent global coalition of health stakeholders.

Find out more

Patient Engagement Management Suite (PEM Suite)

The PFMD network is making sure to aggregate existing knowledge and tools, identifying good practices and coherently combining them before designing accessible and useful avenues for the various audiences that will use them.

The result is the Patient Engagement Management Suite (PEM Suite). A hub of co-created tools, resources and practices to help stakeholders adopt patient engagement in a systematic, efficient and meaningful way.

Find out more

Partnering with top organisations

Explore the collaborative environment

Explore Synapse

What’s hot in patient engagement

X